Quantitative MRI for Myelofibrosis

RecruitingOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

December 22, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Myelofibrosis
Interventions
PROCEDURE

T1 Weighted MRI (magnetic resonance imaging)

"Enrolled subjects will have an MRI scan performed at baseline (within 1 month before beginning therapy), at the time of a scheduled bone marrow biopsy or end of treatment cycle (6 months), and after 12 months.~Please note: Patients in this study will be treated with chemotherapy as determined by the hematologist or the treatment protocol for an independent clinical trial for therapy of myelofibrosis. Treatment and monitoring will be performed under the usual standard of care that includes physical examinations, laboratory testing, and other indicated imaging examinations."

Trial Locations (1)

48109

RECRUITING

University of Michigan Hospital, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER